AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
AAPL   317.86 (+0.36%)
MSFT   179.09 (-1.37%)
AMZN   2,395.66 (-1.08%)
NVDA   338.55 (-2.91%)
CGC   20.32 (+1.55%)
BABA   200.85 (-0.44%)
MU   45.85 (+0.11%)
TSLA   817.77 (-0.13%)
AMD   52.31 (-1.65%)
T   31.60 (+2.50%)
ACB   15.74 (+0.83%)
F   6.06 (+3.77%)
DIS   123.53 (+2.13%)
BAC   25.62 (+5.48%)
Log in

NASDAQ:CUTRCutera Stock Price, Forecast & News

$13.47
+0.82 (+6.48 %)
(As of 05/27/2020 09:11 AM ET)
Add
Compare
Today's Range
$13.00
Now: $13.47
$13.80
50-Day Range
$10.70
MA: $12.79
$14.76
52-Week Range
$9.07
Now: $13.47
$39.15
Volume237,499 shs
Average Volume251,063 shs
Market Capitalization$235.19 million
P/E RatioN/A
Dividend YieldN/A
Beta1.49
Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin revitalization. In addition, the company offers GenesisPlus, CoolGlide, myQ, enlighten SR, and truSculpt iD products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.
Read More
Cutera logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.11 out of 5 stars


Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryN/A
SectorComputer and Technology
Current SymbolNASDAQ:CUTR
CUSIPN/A
Phone415-657-5500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$181.71 million
Book Value$1.92 per share

Profitability

Net Income$-12,350,000.00

Miscellaneous

Employees402
Market Cap$235.19 million
Next Earnings Date8/13/2020 (Estimated)
OptionableOptionable

Receive CUTR News and Ratings via Email

Sign-up to receive the latest news and ratings for CUTR and its competitors with MarketBeat's FREE daily newsletter.

Cutera (NASDAQ:CUTR) Frequently Asked Questions

How has Cutera's stock been impacted by COVID-19 (Coronavirus)?

Cutera's stock was trading at $18.11 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CUTR shares have decreased by 25.6% and is now trading at $13.47. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Cutera?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cutera in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Cutera.

When is Cutera's next earnings date?

Cutera is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Cutera.

How were Cutera's earnings last quarter?

Cutera, Inc. (NASDAQ:CUTR) announced its quarterly earnings results on Thursday, May, 7th. The medical device company reported ($0.60) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.36. The medical device company had revenue of $32.24 million for the quarter, compared to analyst estimates of $35.35 million. Cutera had a negative return on equity of 39.71% and a negative net margin of 9.30%. View Cutera's earnings history.

What guidance has Cutera issued on next quarter's earnings?

Cutera updated its first quarter 2020 After-Hours earnings guidance on Thursday, April, 16th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31.5-32 million, compared to the consensus revenue estimate of $34.53 million.

What price target have analysts set for CUTR?

5 brokerages have issued twelve-month price objectives for Cutera's shares. Their forecasts range from $15.00 to $26.00. On average, they anticipate Cutera's share price to reach $19.67 in the next twelve months. This suggests a possible upside of 46.0% from the stock's current price. View analysts' price targets for Cutera.

Has Cutera been receiving favorable news coverage?

Media stories about CUTR stock have trended somewhat negative this week, InfoTrie reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Cutera earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutCutera.

Who are some of Cutera's key competitors?

What other stocks do shareholders of Cutera own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cutera investors own include AbbVie (ABBV), Gilead Sciences (GILD), Micron Technology (MU), Alibaba Group (BABA), Pfizer (PFE), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Illumina (ILMN), NVIDIA (NVDA) and Palo Alto Networks (PANW).

Who are Cutera's key executives?

Cutera's management team includes the following people:
  • Ms. Sandra A. Gardiner, Exec. VP & CFO (Age 53)
  • Mr. Larry E. Laber, Exec. VP of Sales - North America (Age 48)
  • Mr. Ronald J. Santilli, Exec. Officer (Age 59)
  • Mr. Jason Richey, Interim CEO & Chief Operating Officer
  • Dr. Michael Karavitis, Exec. VP & Chief Technology Officer

What is Cutera's stock symbol?

Cutera trades on the NASDAQ under the ticker symbol "CUTR."

Who are Cutera's major shareholders?

Cutera's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (14.46%), Victory Capital Management Inc. (7.76%), Victory Capital Management Inc. (7.76%), Gamco Investors INC. ET AL (6.47%), Gabelli Funds LLC (3.61%) and State Street Corp (3.61%). Company insiders that own Cutera stock include David A Gollnick, David H Mowry, J Daniel Plants, James A Reinstein and Larry Laber. View institutional ownership trends for Cutera.

Which institutional investors are selling Cutera stock?

CUTR stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, BlackRock Inc., Russell Investments Group Ltd., Two Sigma Investments LP, Parametric Portfolio Associates LLC, Mackay Shields LLC, Essex Investment Management Co. LLC, and Bogle Investment Management L P DE. View insider buying and selling activity for Cutera.

Which institutional investors are buying Cutera stock?

CUTR stock was purchased by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Victory Capital Management Inc., JPMorgan Chase & Co., Federated Hermes Inc., Acadian Asset Management LLC, AQR Capital Management LLC, Deutsche Bank AG, and Voce Capital Management LLC. Company insiders that have bought Cutera stock in the last two years include David H Mowry, J Daniel Plants, and James A Reinstein. View insider buying and selling activity for Cutera.

How do I buy shares of Cutera?

Shares of CUTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Cutera's stock price today?

One share of CUTR stock can currently be purchased for approximately $13.47.

How big of a company is Cutera?

Cutera has a market capitalization of $235.19 million and generates $181.71 million in revenue each year. The medical device company earns $-12,350,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis. Cutera employs 402 workers across the globe.

What is Cutera's official website?

The official website for Cutera is www.cutera.com.

How can I contact Cutera?

Cutera's mailing address is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. The medical device company can be reached via phone at 415-657-5500 or via email at [email protected]

This page was last updated on 5/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.